dimethyl sulfoxide has been researched along with Acute Confusional Senile Dementia in 17 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "The core structures of sodium dodecyl sulfate extracted, pronase digested paired helical filaments of Alzheimer disease were solubilized by heating in dimethyl sulfoxide." | 3.68 | Alzheimer disease paired helical filament core structures contain glycolipid. ( Goux, WJ; Hill, SJ; Jones, CM; Sparkman, DR; White, CL, 1991) |
| "Alzheimer's disease is an age-dependent neurodegenerative disorder that is characterized by a progressive decline in cognitive function." | 1.35 | Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. ( Arita, K; Deguchi-Tawarada, M; Inoue, E; Katahira-Tayama, S; Matsui, C; Oda, Y; Sato, T; Takai, Y; Togawa, A; Yamauchi, E, 2009) |
| "Oxidative stress occurs in brains of Alzheimer's disease (AD) patients." | 1.31 | Differential alterations in antioxidant capacity in cells from Alzheimer patients. ( Gibson, GE; Park, LC; Sheu, KR; Zhang, H, 2000) |
| "Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K+) channels." | 1.30 | Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator. ( Bhagavan, S; Etcheberrigaray, R; Ibarreta, D; Kozikowski, AP; Ma, D, 1998) |
| "A tetraethylammonium-induced increase of intracellular concentrations of calcium, [Ca2+]i, a response that depends on functional 113-picosiemen potassium channels, was also eliminated or markedly reduced by 10 nM beta-amyloid." | 1.29 | Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. ( Alkon, DL; Etcheberrigaray, R; Ito, E; Kim, CS, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Maher, MA | 1 |
| Kandeel, WA | 1 |
| Hammam, OA | 1 |
| Attia, YM | 1 |
| Mahmoud, S | 1 |
| Salah, M | 1 |
| Nikkar, R | 1 |
| Esmaeili-Bandboni, A | 1 |
| Badrikoohi, M | 1 |
| Babaei, P | 1 |
| Parvin, MS | 1 |
| Chlebek, J | 1 |
| Hošťálková, A | 1 |
| Catapano, MC | 1 |
| Lomozová, Z | 1 |
| Macáková, K | 1 |
| Mladěnka, P | 1 |
| Penazzi, L | 1 |
| Lorengel, J | 1 |
| Sündermann, F | 1 |
| Golovyashkina, N | 1 |
| Marre, S | 1 |
| Mathis, CMB | 1 |
| Lewejohann, L | 1 |
| Brandt, R | 1 |
| Bakota, L | 1 |
| Inoue, E | 1 |
| Deguchi-Tawarada, M | 1 |
| Togawa, A | 1 |
| Matsui, C | 1 |
| Arita, K | 1 |
| Katahira-Tayama, S | 1 |
| Sato, T | 1 |
| Yamauchi, E | 1 |
| Oda, Y | 1 |
| Takai, Y | 1 |
| Poduslo, JF | 1 |
| Howell, KG | 1 |
| Olson, NC | 1 |
| Ramirez-Alvarado, M | 1 |
| Kandimalla, KK | 1 |
| Huang, J | 1 |
| Yao, Y | 1 |
| Lin, J | 1 |
| Ye, YH | 1 |
| Sun, WY | 1 |
| Tang Dagger, WX | 1 |
| Maji, SK | 1 |
| Amsden, JJ | 1 |
| Rothschild, KJ | 1 |
| Condron, MM | 1 |
| Teplow, DB | 1 |
| Etcheberrigaray, R | 2 |
| Ito, E | 1 |
| Kim, CS | 1 |
| Alkon, DL | 1 |
| Shen, CL | 1 |
| Murphy, RM | 1 |
| Regelson, W | 1 |
| Harkins, SW | 1 |
| Bhagavan, S | 1 |
| Ibarreta, D | 1 |
| Ma, D | 1 |
| Kozikowski, AP | 1 |
| Thunecke, M | 1 |
| Lobbia, A | 1 |
| Kosciessa, U | 1 |
| Dyrks, T | 1 |
| Oakley, AE | 1 |
| Turner, J | 1 |
| Saenger, W | 1 |
| Georgalis, Y | 1 |
| Misonou, H | 1 |
| Morishima-Kawashima, M | 1 |
| Ihara, Y | 1 |
| Gibson, GE | 1 |
| Zhang, H | 1 |
| Sheu, KR | 1 |
| Park, LC | 1 |
| Sparkman, DR | 1 |
| Goux, WJ | 1 |
| Jones, CM | 1 |
| White, CL | 1 |
| Hill, SJ | 1 |
2 reviews available for dimethyl sulfoxide and Acute Confusional Senile Dementia
1 trial available for dimethyl sulfoxide and Acute Confusional Senile Dementia
15 other studies available for dimethyl sulfoxide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Histopathological evaluation of insulin-DMSO formula designed for direct nose-to-brain delivery.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Brain; Dimethyl Sulfoxide; Drug Delivery Sys | 2022 |
Effects of inhibiting astrocytes and BET/BRD4 chromatin reader on spatial memory and synaptic proteins in rats with Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Chromatin; Cyclic AMP Response Elemen | 2022 |
Interactions of Isoquinoline Alkaloids with Transition Metals Iron and Copper.
Topics: Alzheimer Disease; Chelating Agents; Copper; Cytostatic Agents; Dimethyl Sulfoxide; Galantamine; Hum | 2022 |
DMSO modulates CNS function in a preclinical Alzheimer's disease model.
Topics: Alzheimer Disease; Animals; Dendritic Spines; Dimethyl Sulfoxide; Disease Models, Animal; Drug Evalu | 2017 |
Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Dendrites; Dimethyl Sulfoxide; Hip | 2009 |
Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Peptides; Animals; Dimethyl Sulfoxide; | 2012 |
The solution structure of rat Abeta-(1-28) and its interaction with zinc ion: insights into the scarcity of amyloid deposition in aged rat brain.
Topics: Aged; Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Binding Sites; Brain; Dimethyl | 2004 |
Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Circular Dichroism; Dimethyl Sulfoxid | 2005 |
Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Bombesin; Calcium; Cell Line; Cells, Cultured; Dimethyl Su | 1994 |
Solvent effects on self-assembly of beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biophysical Phenomena; Biophysics; Dimethyl Sulfoxide; Hum | 1995 |
Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator.
Topics: Alzheimer Disease; Calcium; Carcinogens; Cells, Cultured; Dimethyl Sulfoxide; Enzyme Activation; Exc | 1998 |
Aggregation of A beta Alzheimer's disease-related peptide studied by dynamic light scattering.
Topics: Acetonitriles; Alzheimer Disease; Amyloid beta-Peptides; Dimethyl Sulfoxide; Humans; Light; Peptide | 1998 |
Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antioxidants; Apo | 2000 |
Differential alterations in antioxidant capacity in cells from Alzheimer patients.
Topics: Adult; Aged; Alzheimer Disease; Antioxidants; Cells, Cultured; Chromans; Dimethyl Sulfoxide; Female; | 2000 |
Alzheimer disease paired helical filament core structures contain glycolipid.
Topics: Alzheimer Disease; Amino Acids; Dimethyl Sulfoxide; Enzyme-Linked Immunosorbent Assay; Glycolipids; | 1991 |